Loading
Loading
We use strictly necessary cookies to run this site, and analytics cookies to understand how it's used. See our Privacy Policy for details.
Isomorphic Labs Ltd., an Alphabet Inc. spinoff working to accelerate drug discovery, is said to be raising a new funding round.
Summary
The Bloomberg report that revealed the discussions today didn’t specify the size of the deal.
This is a brief wire summary, the full story (linked below) has the complete details.
KazaSec's take
Stories like this are part of why proactive security testing exists, finding the gap before someone else does is always cheaper than responding after the fact.
Coverage details
We've archived 692 other articles touching the same topic (ai, drug discovery, investment) , see the full security news archive.
Relevant from KazaSec
More coverage on this topic
We help organizations find and fix the gaps before they make headlines.